Prelude Therapeutics Ownership & Insider Activity

Prelude Therapeutics (PRLD) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 4.3% of shares outstanding. Institutional investors hold 9.9%.

Shares Outstanding

79.803M

Shares Float

25.313M

Insider Shares Owned

3.423M

Insider % Owned

4.3%

Institutional Shares Held

7.937M

Institutional % Held

9.9%

Ownership Breakdown

Net Insider Activity by Month

Prelude Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Apr 21, 2026	David P Bonita	DIRECTOR	BUY	2.815M	$4.44	$12.5M
Apr 21, 2026	ORBIMED ADVISORS LLC, OrbiMed Capital GP VI LLC, ORBIMED CAPITAL LLC, OrbiMed Genesis GP LLC	DIRECTOR	BUY	2.815M	$4.44	$12.5M